Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates

Molecular Pharmaceutics
Kelly E BurnsDamien Thévenin

Abstract

Localized delivery is vital for the successful development of novel and effective therapeutics for the treatment of cancer. The targeting and delivery described herein is based on the pH (low) insertion peptide (pHLIP), a unique delivery peptide that can selectively target tumors in mice and translocate and release cargo molecules intracellularly based solely on the low extracellular pH intrinsic to cancer cells. In this study, we investigate the efficacy of pHLIP to target and deliver the highly potent and clinically validated microtubule inhibitor monomethyl auristatin E (MMAE) to cancer cells and breast tumors. We show that pHLIP-MMAE conjugates induce a potent cytotoxic effect (>90% inhibition of cell growth) in a concentration- and pH-dependent manner after only 2 h incubation without any apparent disruption of the plasma membrane. pHLIP-MMAE conjugates exhibit between an 11- and 144-fold higher antiproliferative effect at low pH than that at physiological pH and a pronounced pH-dependent cytotoxicity as compared to that of free drug. Furthermore, we demonstrate that a pHLIP-MMAE drug conjugate effectively targets triple-negative breast tumor xenografts in mice. These results indicate that pHLIP-based auristatin conjugates...Continue Reading

References

Sep 1, 1991·British Journal of Cancer·J R Griffiths
Dec 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J L Wike-HooleyH S Reinhold
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Feb 24, 1956·Science·O WARBURG
May 12, 2004·Current Drug Targets·T MinkoY Wang
Dec 14, 2004·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Jul 13, 2005·Journal of Ethnopharmacology·Gordon M Cragg, David J Newman
Mar 4, 2006·Molecular Cancer Research : MCR·Rob CairnsNicholas Denko
Apr 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yana K ReshetnyakDonald M Engelman
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Sep 20, 2006·Cancer Research·Jung-whan Kim, Chi V Dang
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew K RobinsonGregory P Adams
Feb 19, 2008·Expert Review of Anticancer Therapy·Michael J Manyak
Mar 25, 2008·Biophysical Journal·Manuela ZoonensDonald M Engelman
Jul 1, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Robert J GilliesRobert A Gatenby
Oct 3, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yana K ReshetnyakDonald M Engelman
Jun 6, 2009·The Journal of Pharmacology and Experimental Therapeutics·Stephen C AlleyDennis R Benjamin
Jul 29, 2009·Chemistry & Biology·Damien ThéveninDonald M Engelman
Sep 22, 2009·Biochimica Et Biophysica Acta·Monika Musial-SiwekDonald M Engelman
Dec 18, 2009·Journal of Cellular and Molecular Medicine·Johanna ChicheJacques Pouysségur
Jul 21, 2010·Current Opinion in Chemical Biology·Stephen C AlleyPeter D Senter
Nov 5, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ming AnDonald M Engelman
Dec 25, 2010·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Yana K ReshetnyakOleg A Andreev
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Oct 28, 2011·Biochemistry·Dayanjali WijesingheYana K Reshetnyak
Mar 3, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Joshua MillerMatthew K Robinson
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Jan 5, 2013·Cancer Research·Veronica EstrellaRobert J Gillies
Jan 31, 2013·Biochemistry·Anna MoshnikovaYana K Reshetnyak
Jun 27, 2014·Journal of Medicinal Chemistry·John M Lambert, Ravi V J Chari
Jul 9, 2014·Molecular Pharmaceutics·Ramona-Cosmina AdochiteYana K Reshetnyak

❮ Previous
Next ❯

Citations

Dec 5, 2015·ACS Applied Materials & Interfaces·Shi-Ying LiXian-Zheng Zhang
Oct 27, 2015·Biochemistry·Vanessa P NguyenFrancisco N Barrera
Jun 24, 2016·Scientific Reports·Kelly E BurnsDamien Thévenin
Oct 12, 2016·The Journal of Physical Chemistry. B·Theyencheri NarayananYana K Reshetnyak
Jan 4, 2017·Molecular Pharmaceutics·Kelly E BurnsDamien Thévenin
Sep 1, 2016·Angewandte Chemie·Samuel Z HanzWei Qiang
Mar 7, 2018·Proceedings of the National Academy of Sciences of the United States of America·Linden C WyattYana K Reshetnyak
Mar 27, 2019·Cancer Metastasis Reviews·Smitha R PillaiRobert J Gillies
Oct 2, 2015·The Biochemical Journal·Kelly E Burns, Damien Thévenin
Jul 1, 2018·Journal of Fluorescence·Bhagyashree D RaoAmitabha Chattopadhyay
Apr 4, 2019·Frontiers in Oncology·Catherine Vander Linden, Cyril Corbet
May 16, 2020·Frontiers in Bioengineering and Biotechnology·Yana K ReshetnyakDonald M Engelman
Aug 11, 2020·Frontiers in Chemistry·Wenbo ZhangChenxuan Wang
Nov 7, 2019·Journal of Molecular Biology·Victor Vasquez-MontesAlexey S Ladokhin
Dec 15, 2019·Chemistry and Physics of Lipids·Bhagyashree D RaoAmitabha Chattopadhyay
Dec 20, 2019·Molecular Pharmaceutics·Alexander A SvoronosDonald M Engelman
Feb 23, 2020·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sabrina DallavalleRoberta Fruttero
Apr 4, 2021·Cells·Nayanthara U DharmaratnePeter M Glazer
Jun 8, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Tengteng ZouYu Cai
Sep 30, 2020·Langmuir : the ACS Journal of Surfaces and Colloids·Violetta Burns, Blake Mertz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.